| Literature DB >> 33355787 |
Mesut Engin1, Kadir Kaan Ozsin2, Muhammed Savran2, Orhan Guvenc3, Senol Yavuz2, Ahmet Fatih Ozyazicioglu2.
Abstract
INTRODUCTION: Rhythm problems are the most observed complications following coronary artery bypass grafting (CABG), the most common being postoperative atrial fibrillation (PoAF), with an incidence reaching 50% of the patients. In this study, we aimed to investigate the predictive importance of prognostic nutritional index (PNI) and visceral adiposity index (VAI) in predicting PoAF, which occurs after CABG accompanied by cardiopulmonary bypass.Entities:
Keywords: Adiposity; Atrial Fibrillation; Nutritional Assessment; Postoperative Term; Prognosis; Waist Circumference; ymphocyte Count
Mesh:
Year: 2021 PMID: 33355787 PMCID: PMC8522311 DOI: 10.21470/1678-9741-2020-0044
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Patients' preoperative variables and demographic data.
| Characteristics | Group 1 | Group 2 | |
|---|---|---|---|
| (n=144) | (n=55) | ||
| Age (years), mean±SD | 56.9±8.7 | 64.3±10.2 | < 0.001[ |
| Male gender, n (%) | 113 (78.4) | 45 (81.8) | 0.547 |
| Previous PCI, n (%) | 24 (16.6) | 11 (20) | 0.672 |
| Hypertension, n (%) | 85 (59.2) | 46 (83.6) | 0.021 |
| COPD, n (%) | 21 (14.5) | 21 (38.1) | 0.017 |
| BMI (kg/m2) | 29.4±4.6 | 30.4±6.1 | 0.201[ |
| Diabetes mellitus, n (%) | 30 (20.8) | 13 (23.6) | 0.779 |
| Smoking, n (%) | 33 (22.9) | 16 (29) | 0.614 |
| Beta-blocker use, n (%) | 35 (24.3) | 10 (18.1) | 0.572 |
| ACE-I/ARB use, n (%) | 44 (30.4) | 15 (25.4) | 0.718 |
| Ejection fraction (%), mean±SD | 50.8±7.5 | 48.3±6.6 | 0.196[ |
| Left atrial diameter (cm), mean±SD | 3.5±0.3 | 3.7±0.3 | 0.228[ |
| EuroSCORE II | 1.6 (0.5-4.8) | 1.8 (0.5-5.2) | 0.189[ |
Student's t-test
Chi-square test
Mann-Whitney U test (data is expressed as median [interquartile range])
ACE-I=angiotensin-converting enzyme inhibitor; ARB=angiotensin receptor blocker; BMI=body mass index; COPD=chronic obstructive pulmonary disease; EuroSCORE II=European System for Cardiac Operative Risk Evaluation II; PCI=percutaneous coronary intervention; SD=standard deviation
Patients' preoperative laboratory values and perioperative variables.
| Characteristics | Group 1 | Group 2 | |
|---|---|---|---|
| (n=144) | (n=55) | ||
| Hemoglobin (g/dL) | 14.1 (12.2-16) | 13.5 (12.4-16.8) | 0.284[ |
| White blood cell (103/µL) | 8 (6.5-9.9) | 8 (6.5-10.7) | 0.201[ |
| Neutrophil (103/µL) | 4.4 (3.5- 9.7) | 4.7 (3.6-9.9) | 0.267[ |
| Lymphocyte (103/µL) | 2.2 (0.8-3.9) | 1.8 (0.7-3.8) | 0.004[ |
| Creatinine (mg/dL) | 1.1 (0.36-1.49) | 1.2 (0.44-1.48) | 0.556[ |
| LDL-C (mmol/L) | 3.3 (2.3-4.6) | 3.5 (3-4.8) | 0.216[ |
| HDL-C (mmol/L) | 1 (0.7-1.4) | 1.1 (0.7-1.6) | 0.196[ |
| Triglyceride (mmol/L) | 2 (0.7-5.5) | 2.4 (0.9-5.9) | 0.038[ |
| C-reactive protein (mg/dL) | 7.4 (1.6-38) | 9.1 (1.9-40) | 0.018[ |
| Albumin (g/L) | 39.2 (35-53) | 38.7 (34.4-54) | 0.212[ |
| Free T3 (pg/mL) | 2.8 (2.3-5.2) | 3 (2.2-5.5) | 0.283[ |
| Free T4 (ng/dL) | 0.7 (0.5-1.2) | 0.8 (0.5-1.3) | 0.678[ |
| TSH (µIU/L) | 1.3 (0.8-4) | 1.4 (0.7-4.2) | 0.317[ |
| VAI | 3.5 (1.2-14.9) | 5.2 (2.4-15) | <0.001[ |
| PNI | 48 (35-69) | 45 (34-58) | 0.003[ |
| Distal anastomosis number, n | 4 (1-6) | 4 (2-6) | 0.393[ |
| CCt (minutes) | 67 (44-91) | 72 (52-96) | 0.214[ |
| TPt (minutes) | 96 (70-130) | 120 (93-138) | 0.302[ |
| Total chest tube drainage (ml) | 450 (250-1350) | 500 (300-1400) | 0.418[ |
| Inotropic support, n (%) | 8 (5.5) | 12 (21.8) | 0.094 |
| ICU length of stay (days) | 2.5±1 | 3.4±1.2 | < 0.001[ |
| Total hospital length of stay (days) | 6.8±1.2 | 8.5±1.2 | < 0.001[ |
Student's t-test (data is expressed as mean±standard deviation)
Mann-Whitney U test (data is expressed as median [interquartile range])
Chi-square test
CCt=cross-clamp time; HDL-C=high-density lipoprotein cholesterol; ICU=intensive care unit; LDL-C=low-density lipoprotein cholesterol; PNI=prognostic nutritional index; TPt=total perfusion time; TSH=thyroid-stimulating hormone; VAI=visceral adiposity index
Fig. 1Data figure of the area under the curve (AUC), confidence interval (CI), and cutoff values in receiver-operating characteristic (ROC) curve analysis for visceral adiposity index (84.6% sensitivity, 53.1% specificity).
Fig. 2Data figure of the area under the curve (AUC), confidence interval (CI), and cutoff values in receiver-operating characteristic (ROC) curve analysis for prognostic nutritional index (76.4% sensitivity, 48.3% specificity).
| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
| |||
|
|
|
|
| |
Logistic regression analysis to identify factors affecting postoperative atrial fibrillation.
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| Exp (B) | 95% CI | Exp (B) | 95% CI | |||
| Odds ratio | Lower-upper | Odds ratio | Lower-upper | |||
| Age | < 0.001 | 1.151 | 1.008-1.244 | 0.009[ | 1.084[ | 1.010-1-176[ |
| 0.012[ | 1.078[ | 1.008-1.194[ | ||||
| Hypertension | 0.026 | 0.824 | 0.756-0.978 | 0.096[ | 0.876[ | 0.794-1.100[ |
| 0.112[ | 0.914[ | 0.678-1.145[ | ||||
| COPD | 0.023 | 0.653 | 0.312-0.776 | 0.048[ | 0.798[ | 0.664-0.928[ |
| 0.114[ | 0.678[ | 0.479-1.217[ | ||||
| Triglyceride | 0.064 | 0.897 | 0.674-1.010 | -- | -- | -- |
| Lymphocyte | 0.010 | 0.396 | 0.294-0.804 | -- | -- | -- |
| 0.032[ | 0.412[ | 0.374-0.778[ | ||||
| CRP | 0.028 | 1.050 | 1.008-1.212 | 0.108[ | 1.090[ | 0.928-1.234[ |
| 0.176[ | 1.078[ | 0.879-1.194[ | ||||
| PNI | 0.002 | 1.024 | 1.010-1.196 | 0.011[ | 1.052[ | 1.015-1.379[ |
| VAI | < 0.001 | 1.412 | 1.186-1.697 | < 0.001[ | 1.516[ | 1.314-2.154[ |
Multivariate analysis Model 1 (the goodness of fit of the model was confirmed by a P-value of 0.695 in the Hosmer-Lemeshow test)
Multivariate analysis Model 2 (the goodness of fit of the model was confirmed by a P-value of 0.741 in the Hosmer-Lemeshow test)
CI=confidence interval; COPD=chronic obstructive pulmonary disease; CRP=C-reactive protein; PNI=prognostic nutritional index; VAI=visceral adiposity index
| Authors' roles & responsibilities | |
|---|---|
| ME | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| KKO | Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| MS | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| OG | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| SY | Drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| AFO | Drafting the work or revising it critically for important intellectual content; final approval of the version to be published |